跳至主要内容
临床试验/NCT07230366
NCT07230366尚未招募不适用

Clinical Validation of AI-powered Smart Vehicle Assisted Gait Training in Neurodegenerative Disorders

Taipei Medical University Shuang Ho Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年1月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
Gait speed

研究概览

简要总结

This study aims to verify the safety and preliminary clinical benefits of long-term gait training using AI-powered smart electric vehicles for patients with neurodegenerative diseases such as Parkinson's disease and dementia.

详细描述

This study is a single-center, prospective, open-label clinical intervention trial aimed at verifying the clinical safety and preliminary efficacy of an AI-powered smart electric vehicle in gait training for patients with Parkinson's disease and dementia. It is expected to recruit 120 participants aged 50-85 years, who will be randomly assigned to different training durations (2~12 weeks), with training sessions conducted two or three times a week, each lasting 30 to 60 minutes. The primary assessment indicators include gait speed, number of falls, and gait confidence scale, while secondary assessments include satisfaction and balance function. All study data will be coded and preserved for 10 years. The study is funded by the "Healthy Taiwan Cultivation Plan."

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with neurodegenerative diseases (such as Parkinson's disease or dementia).
  • •Age between 50-85 years.
  • •Capable of walking for at least 10 meters, but may have unsteady gait or history of falls.
  • •Able to understand the trial procedures and give informed consent.

排除标准

  • •Severe cardiopulmonary disease or recent major surgery.
  • •Unable to walk or requiring comprehensive physical support.
  • •Severe cognitive impairment preventing understanding of the trial procedures or giving informed consent.
  • •Visual or auditory impairments severe enough to prevent following trial instructions.

研究组 & 干预措施

Treatment arm

Experimental

Gait abnormalities in patients with neurodegenerative diseases

干预措施: BestShape Go Intelligent Generation Transformable Electric Vehicle (Device)

结局指标

主要结局

Gait speed

时间窗: Before & after training (the training sessions will last for 2~12 weeks).

次要结局

  • Number of falls(During 2~12 training sessions.)
  • Patients' gait confidence scale(Before & after training (the training sessions will last for 2~12 weeks).)
  • Patients' balance function(Before & after training (the training sessions will last for 2~12 weeks).)
  • Patients' feedback(Before & after training (the training sessions will last for 2~12 weeks).)
  • Gait length(Before & after training (the training sessions will last for 2~12 weeks).)
  • Number of falls(During 2~12 training sessions.)
  • Patients' gait confidence scale(Before & after training (the training sessions will last for 2~12 weeks).)
  • Patients' balance function(Before & after training (the training sessions will last for 2~12 weeks).)
  • Patients' feedback(Before & after training (the training sessions will last for 2~12 weeks).)

研究者

发起方
Taipei Medical University Shuang Ho Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验